1Suppliers
1Customers
0Debt Items
0Related Chains

Anbio Biotechnology Suppliers

TickerNameConfidenceEvidence
SUPPLIER SUPPLIER 90% For the year ended December 31, 2023, three suppliers accounted for 100% of the total purchases.

Anbio Biotechnology Customers

TickerNameConfidenceEvidence
CUSTOMER CUSTOMER 90% As of December 31, 2023, the balance due from four customers accounted for approximately 30%, 35%, 0%, and 19% of the Company’s total accounts receivable, respectively.

Anbio Biotechnology Debt Obligations

No debt relationships on recordNo publicly disclosed debt instruments or credit facilities found for Anbio Biotechnology.

Anbio Biotechnology Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Anbio Biotechnology.

Anbio Biotechnology Ownership

HolderNameConfidenceEvidence
NNNN-OWNER-GEODE-CAPITAL-MANAGEMENT-LLC GEODE CAPITAL MANAGEMENT, LLC 90% 13F overlay lists GEODE CAPITAL MANAGEMENT, LLC as top holder; 8 tracked holders.

Anbio Biotechnology Extended Supply Chain Network

No secondary connectionsNo correlated companies found through shared supply chain relationships.